{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:37:23Z","timestamp":1773286643676,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00592-014-0572-4","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T10:57:38Z","timestamp":1393498658000},"page":"655-661","source":"Crossref","is-referenced-by-count":6,"title":["Duration of diabetes and effectiveness of insulin in the management of insulin-na\u00efve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results"],"prefix":"10.1007","volume":"51","author":[{"given":"Sang Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Ah","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Sun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Soo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"572_CR1","unstructured":"Diabetes Atlas. http:\/\/www.idf.org . Accessed July 31 2013"},{"key":"572_CR2","unstructured":"Statistics Korea (2009) statistical results about cause of death. http:\/\/www.index.go.kr . Accessed July 31 2013"},{"key":"572_CR3","unstructured":"Type 2 diabetes: practical targets and treatments. http:\/\/www.idf.org\/webdata\/docs\/T2D_practical_tt.pdf . Accessed 31 July 2013"},{"key":"572_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4093\/kdj.2009.33.1.48","volume":"33","author":"S Lim","year":"2009","unstructured":"Lim S, Kim DJ, Jeong IK et al (2009) A nationwide survey about the current status of glycemic control and complications in diabetic patients in 2006: the committee of the Korean diabetes association on the epidemiology of diabetes mellitus. Korean Diabetes J 33:48\u201357","journal-title":"Korean Diabetes J"},{"key":"572_CR5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364\u20131379","journal-title":"Diabetes Care"},{"key":"572_CR6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1742-1241.2008.01757.x","volume":"62","author":"S Jabbour","year":"2008","unstructured":"Jabbour S (2008) Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both? Int J Clin Pract 62:845\u2013847","journal-title":"Int J Clin Pract"},{"key":"572_CR7","first-page":"457","volume":"13","author":"AA Riedel","year":"2007","unstructured":"Riedel AA, Heien H, Wogen J, Plauschinat CA (2007) Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen. Am J Manag Care 13:457\u2013463","journal-title":"Am J Manag Care"},{"key":"572_CR8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1592\/phco.27.8.1102","volume":"27","author":"AA Riedel","year":"2007","unstructured":"Riedel AA, Heien H, Wogen J, Plauschinat CA (2007) Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy 27:1102\u20131110","journal-title":"Pharmacotherapy"},{"key":"572_CR9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diacare.27.7.1535","volume":"27","author":"JB Brown","year":"2004","unstructured":"Brown JB, Nichols GA, Perry A (2004) The burden of treatment failure in type 2 diabetes. Diabetes Care 27:1535\u20131540","journal-title":"Diabetes Care"},{"key":"572_CR10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.clinthera.2007.07.005","volume":"29","author":"A Vinik","year":"2007","unstructured":"Vinik A (2007) Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther 29:1236\u20131253","journal-title":"Clin Ther"},{"issue":"Suppl. 2","key":"572_CR11","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.2337\/dc09-S318","volume":"32","author":"SG Swinnen","year":"2009","unstructured":"Swinnen SG, Hoekstra JB, DeVries JH (2009) Insulin therapy for type 2 diabetes. Diabetes Care 32(Suppl. 2):S253\u2013S259","journal-title":"Diabetes Care"},{"key":"572_CR12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1753-0407.2011.00137.x","volume":"3","author":"ST Tsai","year":"2011","unstructured":"Tsai ST, Pathan F, Ji L et al (2011) First insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in Asia. J Diabetes 3:208\u2013216","journal-title":"J Diabetes"},{"key":"572_CR13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/diacare.28.6.1282","volume":"28","author":"M Davies","year":"2005","unstructured":"Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R, ATLANTUS Study Group (2005) Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 28:1282\u20131288","journal-title":"Diabetes Care"},{"key":"572_CR14","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"MC Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J, Insulin Glargine 4002 Study Investigators (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080\u20133086","journal-title":"Diabetes Care"},{"key":"572_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2337\/diacare.28.1.220","volume":"28","author":"GE Dailey 3rd","year":"2005","unstructured":"Dailey GE 3rd (2005) Early insulin: an important therapeutic strategy. Diabetes Care 28:220\u2013221","journal-title":"Diabetes Care"},{"key":"572_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diacare.28.1.222","volume":"28","author":"MB Davidson","year":"2005","unstructured":"Davidson MB (2005) Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care 28:222\u2013224","journal-title":"Diabetes Care"},{"key":"572_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pdi.433","volume":"20","author":"PD Home","year":"2003","unstructured":"Home PD, Boulton AJM, Jimenez J, Landgraf R, Osterbrink B, Christiansen JS (2003) Issues relating to the early or earlier use of insulin in type 2 diabetes. Pract Diabetes Int 20:63\u201371","journal-title":"Pract Diabetes Int"},{"key":"572_CR18","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T et al (2005) Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study. Diabetes Care 28:2673\u20132679","journal-title":"Diabetes Care"},{"key":"572_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","volume":"367","author":"HC Gerstein","year":"2012","unstructured":"ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367:319\u2013328","journal-title":"N Engl J Med"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0572-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-014-0572-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0572-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:00:35Z","timestamp":1559124035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-014-0572-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1007\/s00592-014-0572-4","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}